uric acid has been researched along with Thrombosis in 32 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Thrombosis: Formation and development of a thrombus or blood clot in the blood vessel.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Elderly, hospitalized coronary artery disease patients on regular aspirin treatment were enrolled from January 2014 to September 2016." | 7.85 | Predictors of high on-aspirin platelet reactivity in elderly patients with coronary artery disease. ( Chen, XH; Feng, XR; Fu, SW; He, XQ; Liang, WY; Liu, ML; Liu, WW; McCaffrey, TA; Zhang, JW, 2017) |
| "A larger LAAPD and an elevated serum uric acid level were found to be independent predictors of LA thrombosis in patients with MS in SR." | 7.81 | Usefulness of the uric acid and CHA₂DS₂-VASc score in prediction of left atrial thrombosis in patients with mitral stenosis and sinus rhythm. ( Akın, F; Akturk, F; Aslan, S; Bırand, A; Celık, O; Ozturk, D; Ozyılmaz, SO; Yıldırım, A, 2015) |
| "To examine the association between renal function, serum uric acid and markers of both pro-inflammatory and prothrombotic state in patients with diabetes mellitus (DM), metabolic syndrome and coronary artery disease." | 7.77 | Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease. ( Buraczyńska, MJ; Kondracki, B; Rychta, E; Waciński, P; Wysokiński, A; Zapolski, T, 2011) |
| "Primary (PMF) and secondary myelofibrosis (SMF) are myeloproliferative neoplasms characterized by high cellular turnover and substantial risk of thrombosis and death." | 5.72 | Higher serum uric acid is associated with higher risks of thrombosis and death in patients with primary myelofibrosis. ( Galusic, D; Holik, H; Krecak, I; Kusec, R; Lucijanic, M; Moric Peric, M; Pejsa, V; Perisa, V; Sedinic, M; Stoos-Veic, T; Zekanovic, I, 2022) |
| "SUA levels in patients with LA thrombus were significantly greater (413." | 5.40 | Serum uric acid and risk of left atrial thrombus in patients with nonvalvular atrial fibrillation. ( Bai, R; Dong, JZ; Du, X; Jiang, CX; Kang, JP; Long, DY; Ma, CS; Ning, M; Salim, M; Sang, CH; Tang, RB; Wu, JH; Yan, XL; Yao, Y; Yu, RH, 2014) |
| "The role of uric acid (UA) in the process of atherothrombosis is controversial." | 5.12 | Usefulness of uric acid to predict changes in C-reactive protein and interleukin-6 in 3-year period in Italians aged 21 to 98 years. ( Bandinelli, S; Cherubini, A; Ferrucci, L; Lauretani, F; Maggio, M; Miller, E; Najjar, SS; Ruggiero, C; Senin, U, 2007) |
| " There were statistically significant differences between the two groups in terms of age, body mass index (BMI), N-terminal prohormone of brain natriuretic peptide NT-probNP, fibrinogen, CHA2DS2-VASC [congestive Heart Failure, Hypertension, Age (75 or older), diabetes mellitus, stroke, vascular disease, age (65-74), sex category] score, paroxysmal atrial fibrillation, renal insufficiency, D-dimer, heart failure, and serum uric acid (p<0." | 4.31 | Predictive value of echocardiography combined with CT angiography for left atrial appendage thrombosis in patients with non-valvular atrial fibrillation. ( Xing, LM; Zhong, J, 2023) |
| "Elderly, hospitalized coronary artery disease patients on regular aspirin treatment were enrolled from January 2014 to September 2016." | 3.85 | Predictors of high on-aspirin platelet reactivity in elderly patients with coronary artery disease. ( Chen, XH; Feng, XR; Fu, SW; He, XQ; Liang, WY; Liu, ML; Liu, WW; McCaffrey, TA; Zhang, JW, 2017) |
| "A larger LAAPD and an elevated serum uric acid level were found to be independent predictors of LA thrombosis in patients with MS in SR." | 3.81 | Usefulness of the uric acid and CHA₂DS₂-VASc score in prediction of left atrial thrombosis in patients with mitral stenosis and sinus rhythm. ( Akın, F; Akturk, F; Aslan, S; Bırand, A; Celık, O; Ozturk, D; Ozyılmaz, SO; Yıldırım, A, 2015) |
| "To examine the association between renal function, serum uric acid and markers of both pro-inflammatory and prothrombotic state in patients with diabetes mellitus (DM), metabolic syndrome and coronary artery disease." | 3.77 | Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease. ( Buraczyńska, MJ; Kondracki, B; Rychta, E; Waciński, P; Wysokiński, A; Zapolski, T, 2011) |
| "The role of uric acid (UA) in the process of atherosclerosis and atherotrombosis is controversial." | 3.73 | Uric acid and inflammatory markers. ( Bandinelli, S; Ble, A; Bos, AJ; Cherubini, A; Dixit, VD; Ferrucci, L; Lauretani, F; Maggio, M; Ruggiero, C; Senin, U, 2006) |
| "Arterial platelet thrombosis induced by topical superfusion with adenosine diphosphate (ADP) is enhanced by tranylcypromine, an inhibitor of prostacyclin-synthetase." | 3.67 | The effect of free radical scavengers on "in vivo" induced arterial thrombosis in relation to the arachidonate cascade. ( Andries, R; Bourgain, RH; Braquet, P; Deby, C, 1985) |
| "Accumulating evidence suggests that hemiparesis exerts a protective effect against gout via the down-regulation of mechanical and neural modulators of inflammation in neurologically impaired extremities." | 2.46 | Polyarticular gout attacks following cerebrovascular accidents: is hemiparesis in fact protective? 2 cases and a review of the literature. ( Furer, V; Hsiao, SJ; Samuels, J; Vaynrub, M, 2010) |
| "Primary (PMF) and secondary myelofibrosis (SMF) are myeloproliferative neoplasms characterized by high cellular turnover and substantial risk of thrombosis and death." | 1.72 | Higher serum uric acid is associated with higher risks of thrombosis and death in patients with primary myelofibrosis. ( Galusic, D; Holik, H; Krecak, I; Kusec, R; Lucijanic, M; Moric Peric, M; Pejsa, V; Perisa, V; Sedinic, M; Stoos-Veic, T; Zekanovic, I, 2022) |
| "SUA levels in patients with LA thrombus were significantly greater (413." | 1.40 | Serum uric acid and risk of left atrial thrombus in patients with nonvalvular atrial fibrillation. ( Bai, R; Dong, JZ; Du, X; Jiang, CX; Kang, JP; Long, DY; Ma, CS; Ning, M; Salim, M; Sang, CH; Tang, RB; Wu, JH; Yan, XL; Yao, Y; Yu, RH, 2014) |
| " These results were obtained with an average dosage of 19 +/- 4." | 1.29 | [Long-term hematological management of cyanotic congenital heart diseases]. ( Cornu, P, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (50.00) | 18.7374 |
| 1990's | 2 (6.25) | 18.2507 |
| 2000's | 3 (9.38) | 29.6817 |
| 2010's | 7 (21.88) | 24.3611 |
| 2020's | 4 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Tang, L | 1 |
| Xia, Y | 1 |
| Fang, L | 1 |
| Zhong, J | 1 |
| Xing, LM | 1 |
| Mineiro, MF | 1 |
| Patricio, ES | 1 |
| Peixoto, ÁS | 1 |
| Araujo, TLS | 1 |
| da Silva, RP | 1 |
| Moretti, AIS | 1 |
| Lima, FS | 1 |
| Laurindo, FRM | 1 |
| Meotti, FC | 1 |
| Lucijanic, M | 1 |
| Krecak, I | 1 |
| Galusic, D | 1 |
| Sedinic, M | 1 |
| Holik, H | 1 |
| Perisa, V | 1 |
| Moric Peric, M | 1 |
| Zekanovic, I | 1 |
| Stoos-Veic, T | 1 |
| Pejsa, V | 1 |
| Kusec, R | 1 |
| Zhang, JW | 1 |
| Liu, WW | 1 |
| McCaffrey, TA | 1 |
| He, XQ | 1 |
| Liang, WY | 1 |
| Chen, XH | 1 |
| Feng, XR | 1 |
| Fu, SW | 1 |
| Liu, ML | 1 |
| Atıl, A | 1 |
| Deniz, A | 1 |
| Ozturk, D | 1 |
| Celık, O | 1 |
| Akın, F | 1 |
| Akturk, F | 1 |
| Aslan, S | 1 |
| Ozyılmaz, SO | 1 |
| Bırand, A | 1 |
| Yıldırım, A | 1 |
| Nattel, S | 1 |
| Tang, RB | 1 |
| Dong, JZ | 1 |
| Yan, XL | 1 |
| Du, X | 1 |
| Kang, JP | 1 |
| Wu, JH | 1 |
| Yu, RH | 1 |
| Long, DY | 1 |
| Ning, M | 1 |
| Sang, CH | 1 |
| Jiang, CX | 1 |
| Salim, M | 1 |
| Bai, R | 1 |
| Yao, Y | 1 |
| Ma, CS | 1 |
| Hsiao, SJ | 1 |
| Vaynrub, M | 1 |
| Furer, V | 1 |
| Samuels, J | 1 |
| Zapolski, T | 1 |
| Waciński, P | 1 |
| Kondracki, B | 1 |
| Rychta, E | 1 |
| Buraczyńska, MJ | 1 |
| Wysokiński, A | 1 |
| Saito, A | 2 |
| Ruggiero, C | 2 |
| Cherubini, A | 2 |
| Ble, A | 1 |
| Bos, AJ | 1 |
| Maggio, M | 2 |
| Dixit, VD | 1 |
| Lauretani, F | 2 |
| Bandinelli, S | 2 |
| Senin, U | 2 |
| Ferrucci, L | 2 |
| Miller, E | 1 |
| Najjar, SS | 1 |
| Bourde, CH | 1 |
| Newland, H | 3 |
| Nordöy, A | 1 |
| Bourgain, RH | 2 |
| Deby, C | 2 |
| Deby-Dupont, G | 1 |
| Andries, R | 2 |
| Cornu, P | 1 |
| Ceriello, A | 1 |
| Bortolotti, N | 1 |
| Pirisi, M | 1 |
| Crescentini, A | 1 |
| Tonutti, L | 1 |
| Motz, E | 1 |
| Russo, A | 1 |
| Giacomello, R | 1 |
| Stel, G | 1 |
| Taboga, C | 1 |
| Klein, S | 1 |
| Marré, E | 1 |
| Koza, KD | 1 |
| Heidelmann, G | 2 |
| Algan, B | 1 |
| Leyder, C | 1 |
| Marchal, H | 1 |
| Geoffroy, D | 1 |
| Marquis, A | 1 |
| Braquet, P | 1 |
| Marx, H | 1 |
| Soroka, RJ | 1 |
| Rose, FL | 1 |
| Esmond, WG | 1 |
| Ota, K | 1 |
| Shimoji, T | 1 |
| Maeda, K | 1 |
| Kobayashi, K | 1 |
| Fessel, WJ | 1 |
| Thiele, P | 1 |
| Gärtner, A | 1 |
| Schneider, V | 1 |
| Tellkamp, F | 1 |
| Balík, J | 1 |
| Laufbergerová, J | 1 |
| Bourde, C | 1 |
| Cepelák, V | 1 |
| Barcal, R | 1 |
| Lang, N | 1 |
| Cepeláková, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Assessing the Role of the NLRP3 Inflammasome in Driving Inflammation in Affected Joints of Patients With Intercritical Gout[NCT04125459] | 8 participants (Anticipated) | Observational | 2020-01-22 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for uric acid and Thrombosis
| Article | Year |
|---|---|
Polyarticular gout attacks following cerebrovascular accidents: is hemiparesis in fact protective? 2 cases and a review of the literature.
Topics: Central Nervous System; Gout; Humans; Male; Middle Aged; Paresis; Rheumatic Diseases; Stroke; Thromb | 2010 |
[The portable hemofiltration-system].
Topics: Adsorption; Animals; beta 2-Microglobulin; Blood Urea Nitrogen; Creatinine; Endothelial Cells; Hemof | 2004 |
1 trial available for uric acid and Thrombosis
| Article | Year |
|---|---|
Usefulness of uric acid to predict changes in C-reactive protein and interleukin-6 in 3-year period in Italians aged 21 to 98 years.
Topics: Adult; Aged; Aged, 80 and over; Atherosclerosis; C-Reactive Protein; Cardiovascular Diseases; Cohort | 2007 |
29 other studies available for uric acid and Thrombosis
| Article | Year |
|---|---|
Correlation between Left Atrial Thrombosis and Neutrophil-to-Lymphocyte Ratio upon Non-Valvular Atrial Fibrillation.
Topics: Atrial Fibrillation; Humans; Lymphocytes; Neutrophils; Retrospective Studies; Risk Assessment; Throm | 2022 |
Predictive value of echocardiography combined with CT angiography for left atrial appendage thrombosis in patients with non-valvular atrial fibrillation.
Topics: Atrial Appendage; Atrial Fibrillation; Computed Tomography Angiography; Echocardiography, Transesoph | 2023 |
Urate hydroperoxide oxidizes endothelial cell surface protein disulfide isomerase-A1 and impairs adherence.
Topics: Catalytic Domain; Cell Adhesion; Cell Membrane; Cell Survival; Chromatography, Liquid; Cysteine; End | 2020 |
Higher serum uric acid is associated with higher risks of thrombosis and death in patients with primary myelofibrosis.
Topics: Humans; Male; Primary Myelofibrosis; Prognosis; Retrospective Studies; Risk Factors; Thrombosis; Uri | 2022 |
Predictors of high on-aspirin platelet reactivity in elderly patients with coronary artery disease.
Topics: Aged; Aged, 80 and over; Aspirin; Cardiovascular Diseases; Coronary Artery Disease; Female; Humans; | 2017 |
Could be serum uric acid a risk factor for thrombosis and/or uveitis in Behcet's disease?
Topics: Adult; Behcet Syndrome; Biomarkers; Female; Humans; Hyperuricemia; Male; Medical Records; Middle Age | 2018 |
Usefulness of the uric acid and CHA₂DS₂-VASc score in prediction of left atrial thrombosis in patients with mitral stenosis and sinus rhythm.
Topics: Adult; Biomarkers; Decision Support Techniques; Echocardiography, Transesophageal; Female; Heart Atr | 2015 |
Serum uric acid concentration and left atrial thrombus: biomarker, pathophysiological indicator, or innocent bystander?
Topics: Atrial Fibrillation; Catheter Ablation; Female; Heart Atria; Heart Diseases; Humans; Male; Thrombosi | 2014 |
Serum uric acid and risk of left atrial thrombus in patients with nonvalvular atrial fibrillation.
Topics: Atrial Fibrillation; Biomarkers; Catheter Ablation; China; Echocardiography, Transesophageal; Female | 2014 |
Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.
Topics: Aged; Biomarkers; Coronary Artery Disease; Diabetes Mellitus; Female; Humans; Hyperuricemia; Inflamm | 2011 |
Uric acid and inflammatory markers.
Topics: Aged; Aged, 80 and over; Atherosclerosis; Biomarkers; C-Reactive Protein; Cytokines; Female; Humans; | 2006 |
[Place of hyperuricemia and gout in the etiology of retina vascular disorders].
Topics: Female; Gout; Humans; Male; Retinal Hemorrhage; Retinal Vessels; Thrombosis; Uric Acid | 1967 |
Effect of large doses of warfarin sodium on haemostasis and on ADP-induced platelet aggregation in vivo in the rat. A survey of experimental thrombosis and coumarin anticoagulant therapy.
Topics: Adenine Nucleotides; Animals; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Coumarins | 1967 |
Enhancement of arterial thromboformation by uric acid, a free radical scavenger.
Topics: Adenosine Diphosphate; Animals; Arterial Occlusive Diseases; Epoprostenol; Free Radicals; Photometry | 1982 |
[Long-term hematological management of cyanotic congenital heart diseases].
Topics: Adolescent; Adult; Child; Child, Preschool; Heart Defects, Congenital; Hematologic Diseases; Humans; | 1994 |
Total plasma antioxidant capacity predicts thrombosis-prone status in NIDDM patients.
Topics: Antioxidants; Ascorbic Acid; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; | 1997 |
Antithrombotic effect of sulphinpyrazone.
Topics: Animals; Humans; Rabbits; Rats; Sulfinpyrazone; Thrombosis; Uric Acid | 1978 |
[Retinal thromboses with metabolic disturbances (author's transl)].
Topics: Adult; Age Factors; Aged; Female; Glucose; Humans; Hyperglycemia; Hyperlipidemias; Hypertension; Lip | 1978 |
[Etiology of retinal venous thromboses].
Topics: Adult; Arteriosclerosis; Diabetic Retinopathy; Female; Humans; Hypertension; Retinal Vein; Thrombosi | 1976 |
The effect of free radical scavengers on "in vivo" induced arterial thrombosis in relation to the arachidonate cascade.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Cyclooxygenase Inhibitors; Free Radicals; Male; Rats; | 1985 |
[Significance of hyperuricemia in chronic arterial occlusive disease and in post-thrombotic syndrome].
Topics: Arterial Occlusive Diseases; Chronic Disease; Humans; Thrombosis; Uric Acid | 1974 |
The Vivacell--a sterile, disposable, high performance, low prime hemodialyzer.
Topics: Biocompatible Materials; Blood Pressure; Cellulose; Creatinine; Disposable Equipment; Humans; Kidney | 1973 |
Bemberg hollow fiber capillary kidney.
Topics: Animals; Blood Flow Velocity; Blood Pressure; Blood Urea Nitrogen; Capillaries; Cellulose; Copper; C | 1973 |
Hyperuricemia in health and disease.
Topics: Arteriosclerosis; Arthritis; Blood Group Antigens; Carbohydrate Metabolism; Diabetes Complications; | 1972 |
[Current problems of gout].
Topics: Blood Glucose; Cholesterol; Coronary Disease; Diabetes Complications; Female; Gout; Humans; Hypercho | 1970 |
[Participation of uric acid in thromboses of the eye].
Topics: Aged; Blood Pressure Determination; Eye Diseases; Female; Humans; Male; Middle Aged; Sex Factors; Th | 1971 |
Antagonism of the anti-thrombotic effect of warfarin by uric acid.
Topics: Adenine Nucleotides; Animals; Blood Coagulation; Blood Coagulation Tests; Injections, Intraperitonea | 1968 |
[Hyperuricemia and gout in retinal vascular accidents. New etiological and therapeutic data].
Topics: Adult; Aged; Female; Gout; Humans; Male; Middle Aged; Retinal Hemorrhage; Retinal Vessels; Thromboph | 1963 |
[On the nyctohemeral rhythm in fibrinolysis].
Topics: Arginase; Blood Platelets; Esterases; Fibrinolysis; Humans; Oxidoreductases; Periodicity; Thrombelas | 1966 |